$OPK
OPKO HEALTH, INC. Stock $opk

$opk Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000143774923030395 Filed on November 06, 2023

Income Statement

Concept	2023 Q4	2023 Q3	2022 Q3
Revenue	$181.9M	$178.6M	$179.7M
YoY Change	-1.85%	-0.64%	-53.41%
Cost Of Revenue	$137.2M	$130.9M	$148.4M
YoY Change	6.07%	-11.82%	-39.15%
Gross Profit	$44.70M	$47.70M	$31.30M
YoY Change	-20.17%	52.4%	-77.94%
Gross Profit Margin	24.57%	26.71%	17.41%
Selling, General & Admin	$72.90M	$72.24M	$79.67M
YoY Change	-1.48%	-9.33%	-24.21%
% of Gross Profit	163.09%	151.45%	254.56%
Research & Development	$19.40M	$19.44M	$18.79M
YoY Change	-0.66%	3.42%	2.65%
% of Gross Profit	43.4%	40.74%	60.04%
Depreciation & Amortization	$21.50M	$26.18M	$28.00M
YoY Change	-18.75%	-6.47%	47.63%
% of Gross Profit	48.1%	54.89%	89.44%
Operating Expenses	$250.9M	$243.0M	$267.6M
YoY Change	4.3%	-9.18%	-23.11%
Operating Profit	-$206.2M	-$64.41M	-$87.82M
YoY Change	11.72%	-26.66%	-332.17%
Interest Expense	-$2.499M	$3.384M	-$1.904M
YoY Change	15.59%	-277.73%	-36.49%
% of Operating Profit
Other Income/Expense, Net	-$3.400M	-$13.97M	-$38.56M
YoY Change	-92.4%	-63.76%	506.78%
Pretax Income	-$72.50M	-$78.38M	-$126.4M
YoY Change	-29.05%	-37.98%	-501.55%
Income Tax	-$6.000M	$6.075M	-$40.33M
% Of Pretax Income
Net Earnings	-$66.48M	-$84.47M	-$86.09M
YoY Change	-22.0%	-1.88%	-399.56%
Net Earnings / Revenue	-36.55%	-47.3%	-47.9%
Basic Earnings Per Share	-$0.09	-$0.11	-$0.11
Diluted Earnings Per Share	-$0.09	-$0.11	-$0.11
COMMON SHARES
Basic Shares Outstanding	773.1M	773.1M	772.0M shares
Diluted Shares Outstanding		751.5M	750.4M shares

Balance Sheet

Concept	2023 Q4	2023 Q3	2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$95.90M	$138.6M	$180.8M
YoY Change	-37.4%	-23.36%	21.7%
Cash & Equivalents	$95.88M	$138.6M	$180.8M
Short-Term Investments
Other Short-Term Assets	$7.673M	$7.003M	$6.340M
YoY Change	22.73%	10.46%	-42.38%
Inventory	$65.70M	$68.96M	$71.43M
Prepaid Expenses
Receivables	$123.4M	$117.4M	$123.2M
Other Receivables	$6.821M	$9.100M	$15.06M
Total Short-Term Assets	$309.5M	$357.2M	$414.0M
YoY Change	-21.56%	-13.7%	-25.75%
LONG-TERM ASSETS
Property, Plant & Equipment	$75.43M	$78.17M	$119.7M
YoY Change	-37.97%	-34.72%	-15.08%
Goodwill	$598.3M	$594.5M	$573.5M
YoY Change	0.4%	3.65%	-14.98%
Intangibles	$740.3M	$758.4M
YoY Change	-10.11%
Long-Term Investments	$16.08M	$19.40M	$77.80M
YoY Change	-42.73%	-75.07%	561.99%
Other Assets	$9.080M	$9.333M	$9.636M
YoY Change	4.62%	-3.14%	10.2%
Total Long-Term Assets	$1.702B	$1.699B	$1.811B
YoY Change	-3.98%	-6.15%	-2.65%
TOTAL ASSETS
Total Short-Term Assets	$309.5M	$357.2M	$414.0M
Total Long-Term Assets	$1.702B	$1.699B	$1.811B
Total Assets	$2.012B	$2.057B	$2.225B
YoY Change	-7.18%	-7.56%	-7.98%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$69.68M	$66.80M	$49.75M
YoY Change	4.01%	34.28%	-47.3%
Accrued Expenses	$90.09M	$92.37M	$112.0M
YoY Change	-8.33%	-17.54%	-31.67%
Deferred Revenue	$0.00		$257.0K
YoY Change			-91.44%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$1.993M	$1.772M	$96.55M
YoY Change	-94.94%	-98.16%	478.1%
Total Short-Term Liabilities	$200.1M	$200.6M	$267.3M
YoY Change	-6.29%	-24.96%	-5.57%
LONG-TERM LIABILITIES
Long-Term Debt	$7.727M	$7.927M	$155.1M
YoY Change	-96.59%	-94.89%	9183.96%
Other Long-Term Liabilities	$27.19M	$25.62M	$22.55M
YoY Change	-0.66%	13.59%	7.44%
Total Long-Term Liabilities	$422.4M	$411.6M	$328.4M
YoY Change	7.73%	25.3%	-11.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$200.1M	$200.6M	$267.3M
Total Long-Term Liabilities	$422.4M	$411.6M	$328.4M
Total Liabilities	$622.5M	$612.1M	$595.7M
YoY Change	2.79%	2.75%	-8.64%
SHAREHOLDERS EQUITY
Retained Earnings	-$2.012B	-$1.945B	-$1.738B
YoY Change	10.36%	11.95%	20.82%
Common Stock	$7.820M	$7.817M	$7.814M
YoY Change	0.09%	0.04%	13.25%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.389B	$1.445B	$1.629B
YoY Change
Total Liabilities & Shareholders Equity	$2.012B	$2.057B	$2.225B
YoY Change	-7.18%	-7.56%	-7.98%

Cashflow Statement

Concept	2023 Q4	2023 Q3	2022 Q3
OPERATING ACTIVITIES
Net Income	-$66.48M	-$84.47M	-$86.09M
YoY Change	-22.0%	-1.88%	-399.56%
Depreciation, Depletion And Amortization	$21.50M	$26.18M	$28.00M
YoY Change	-18.75%	-6.47%	47.63%
Cash From Operating Activities	-$38.29M	$33.10M	-$32.24M
YoY Change	21.11%	-202.68%	-196.53%
INVESTING ACTIVITIES
Capital Expenditures	$3.022M	$4.200M	-$7.612M
YoY Change	-52.3%	-155.18%	5.23%
Acquisitions
YoY Change
Other Investing Activities	$1.604M	$700.0K	$2.930M
YoY Change	-204.43%	-76.11%	-95.26%
Cash From Investing Activities	-$1.418M	-$3.600M	-$4.682M
YoY Change	-81.99%	-23.11%	-108.58%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-3.751M	2.100M	8.444M
YoY Change	-136.98%	-75.13%	-298.4%
NET CHANGE
Cash From Operating Activities	-38.29M	33.10M	-32.24M
Cash From Investing Activities	-1.418M	-3.600M	-4.682M
Cash From Financing Activities	-3.751M	2.100M	8.444M
Net Change In Cash	-43.46M	31.60M	-28.47M
YoY Change	48.1%	-210.98%	-134.01%
FREE CASH FLOW
Cash From Operating Activities	-$38.29M	$33.10M	-$32.24M
Capital Expenditures	$3.022M	$4.200M	-$7.612M
Free Cash Flow	-$41.32M	$28.90M	-$24.62M
YoY Change	8.85%	-217.37%	-160.61%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	781711885
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	781306164
CY2023Q3	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	8655082
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	8655082
CY2022Q4	opk	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Goodwill And Intangible Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedGoodwillAndIntangibleAssets	1600000000	usd
CY2022Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	1000000000	usd
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	pure
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	pure
	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-33528
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	75-2402409
	dei	Entity Address Address Line1 EntityAddressAddressLine1	4400 Biscayne Blvd.
	dei	Entity Address City Or Town EntityAddressCityOrTown	Miami
	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	33137
	dei	City Area Code CityAreaCode	305
	dei	Local Phone Number LocalPhoneNumber	575-4100
	dei	Security12b Title Security12bTitle	Common Stock, par value $0.01 per share
	dei	Trading Symbol TradingSymbol	OPK
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	773056533
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	138621000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	153191000	usd
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	117449000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	127312000	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	68960000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	74060000	usd
CY2023Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	32209000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	39962000	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	357239000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	394525000	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	78170000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	82879000	usd
CY2023Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	758414000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	823520000	usd
CY2023Q3	opk	Capitalized Research And Development In Process CapitalizedResearchAndDevelopmentInProcess	195000000	usd
CY2022Q4	opk	Capitalized Research And Development In Process CapitalizedResearchAndDevelopmentInProcess	195000000	usd
CY2023Q3	us-gaap	Goodwill Goodwill	594457000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	595851000	usd
CY2023Q3	us-gaap	Long Term Investments LongTermInvestments	19377000	usd
CY2022Q4	us-gaap	Long Term Investments LongTermInvestments	28080000	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	44690000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	38725000	usd
CY2023Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	9333000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	8679000	usd
CY2023Q3	us-gaap	Assets Assets	2056680000	usd
CY2022Q4	us-gaap	Assets Assets	2167259000	usd
CY2023Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	66801000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	66993000	usd
CY2023Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	92368000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	98269000	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	11267000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	11628000	usd
CY2023Q3	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	0	usd
CY2022Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	3050000	usd
CY2023Q3	us-gaap	Loans Payable To Bank Current LoansPayableToBankCurrent	30118000	usd
CY2022Q4	us-gaap	Loans Payable To Bank Current LoansPayableToBankCurrent	33540000	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	200554000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	213480000	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	34649000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	27963000	usd
CY2023Q3	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	213285000	usd
CY2022Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	210371000	usd
CY2023Q3	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	138007000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	126426000	usd
CY2023Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	25617000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	27371000	usd
CY2023Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	411558000	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	392131000	usd
CY2023Q3	us-gaap	Liabilities Liabilities	612112000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	605611000	usd
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	7817000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	7813000	usd
CY2023Q3	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	1791000	usd
CY2022Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	1791000	usd
CY2023Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	3430340000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	3421872000	usd
CY2023Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-46495000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-43323000	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1945303000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1822923000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	1444568000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	1561648000	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2056680000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2167259000	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	178595000	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	179744000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	681591000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	818856000	usd
CY2023Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	72240000	usd
CY2022Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	79674000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	227676000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	298675000	usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	19435000	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	18792000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	15315000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	70199000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	54359000	usd
CY2023Q3	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-1125000	usd
CY2022Q3	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-754000	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-1023000	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-685000	usd
CY2023Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	21534000	usd
CY2022Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	21407000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	64543000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	66225000	usd
CY2023Q3	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets	-0	usd
CY2022Q3	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets	-0	usd
	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets	-0	usd
	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets	15365000	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	243002000	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	267564000	usd
	us-gaap	Operating Expenses OperatingExpenses	769566000	usd
	us-gaap	Operating Expenses OperatingExpenses	989840000	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-64407000	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-87820000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-87975000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-170984000	usd
CY2023Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	970000	usd
CY2022Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	667000	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	3077000	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	838000	usd
CY2023Q3	us-gaap	Interest Expense InterestExpense	3384000	usd
CY2022Q3	us-gaap	Interest Expense InterestExpense	3017000	usd
	us-gaap	Interest Expense InterestExpense	10053000	usd
	us-gaap	Interest Expense InterestExpense	8754000	usd
CY2023Q3	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	88000	usd
CY2022Q3	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	446000	usd
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-829000	usd
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	652000	usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-11645000	usd
CY2022Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-36651000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-16045000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-111091000	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-13971000	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-38555000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-23850000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-118355000	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-78378000	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-126375000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-111825000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-289339000	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	6075000	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-40327000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	10456000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-46524000	usd
CY2023Q3	opk	Income Loss From Continuing Operations Net Of Tax Before Equity Method Investments And Noncontrolling Interest Total IncomeLossFromContinuingOperationsNetOfTaxBeforeEquityMethodInvestmentsAndNoncontrollingInterestTotal	-84453000	usd
CY2022Q3	opk	Income Loss From Continuing Operations Net Of Tax Before Equity Method Investments And Noncontrolling Interest Total IncomeLossFromContinuingOperationsNetOfTaxBeforeEquityMethodInvestmentsAndNoncontrollingInterestTotal	-86048000	usd
	opk	Income Loss From Continuing Operations Net Of Tax Before Equity Method Investments And Noncontrolling Interest Total IncomeLossFromContinuingOperationsNetOfTaxBeforeEquityMethodInvestmentsAndNoncontrollingInterestTotal	-122281000	usd
	opk	Income Loss From Continuing Operations Net Of Tax Before Equity Method Investments And Noncontrolling Interest Total IncomeLossFromContinuingOperationsNetOfTaxBeforeEquityMethodInvestmentsAndNoncontrollingInterestTotal	-242815000	usd
CY2023Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-20000	usd
CY2022Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-43000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-99000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-359000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-84473000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-86091000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-122380000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-243174000	usd
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.11
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.11
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.16
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.34
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	751525007
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	750396263
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	751716692
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	708121980
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-84473000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-86091000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-122380000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-243174000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-9554000	usd
CY2022Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-8855000	usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-3173000	usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-27531000	usd
CY2023Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-94027000	usd
CY2022Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-94946000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-125553000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-270705000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	1535348000	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3218000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	28000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-84473000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-9553000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	1444568000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	1561648000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	8745000	usd
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	-273000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-122380000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-3172000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	1444568000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	1718799000	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3390000	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	-463000	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	2288000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-86091000	usd
CY2022Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-8855000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	1629068000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	1685126000	usd
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	-688000	usd
	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	221662000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-243174000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-27531000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	1629068000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-122380000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-243174000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	79315000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	82195000	usd
	us-gaap	Paid In Kind Interest PaidInKindInterest	2057000	usd
	us-gaap	Paid In Kind Interest PaidInKindInterest	2057000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	908000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	863000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-99000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-359000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	8746000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	15315000	usd
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-1444000	usd
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	814000	usd
	opk	Changes In Fair Value Gain Loss In Equity Securities Fvni And Derivative Instruments ChangesInFairValueGainLossInEquitySecuritiesFvniAndDerivativeInstruments	-14406000	usd
	opk	Changes In Fair Value Gain Loss In Equity Securities Fvni And Derivative Instruments ChangesInFairValueGainLossInEquitySecuritiesFvniAndDerivativeInstruments	-104126000	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-1023000	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-685000	usd
	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	-0	usd
	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	15365000	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	7307000	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-48883000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-8741000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-130052000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-4082000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-11314000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-10220000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	3977000	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	2666000	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-211000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	191000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-25000000	usd
	opk	Increase Decrease In Foreign Currency Measurement IncreaseDecreaseInForeignCurrencyMeasurement	24000	usd
	opk	Increase Decrease In Foreign Currency Measurement IncreaseDecreaseInForeignCurrencyMeasurement	10541000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-2000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-73000	usd
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-1372000	usd
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-82631000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	10097000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-63569000	usd
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	5000000	usd
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	-0	usd
	us-gaap	Proceeds From Sale Of Equity Securities Fv Ni ProceedsFromSaleOfEquitySecuritiesFvNi	364000	usd
	us-gaap	Proceeds From Sale Of Equity Securities Fv Ni ProceedsFromSaleOfEquitySecuritiesFvNi	0	usd
	us-gaap	Proceeds From Divestiture Of Interest In Subsidiaries And Affiliates ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates	0	usd
	us-gaap	Proceeds From Divestiture Of Interest In Subsidiaries And Affiliates ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates	115423000	usd
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	-0	usd
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	-228000	usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	1109000	usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	1501000	usd
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	13253000	usd
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	18242000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-16780000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	98910000	usd
	opk	Proceeds From Stock Options Exercised Net ProceedsFromStockOptionsExercisedNet	273000	usd
	opk	Proceeds From Stock Options Exercised Net ProceedsFromStockOptionsExercisedNet	688000	usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	515318000	usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	893548000	usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	519597000	usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	880033000	usd
	us-gaap	Repayments Of Senior Debt RepaymentsOfSeniorDebt	3000000	usd
	us-gaap	Repayments Of Senior Debt RepaymentsOfSeniorDebt	-0	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-7552000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	12827000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-335000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-2040000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-14570000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	46128000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	153191000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	134710000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	138621000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	180838000	usd
	us-gaap	Interest Paid Net InterestPaidNet	10748000	usd
	us-gaap	Interest Paid Net InterestPaidNet	7019000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-823000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	4471000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	713000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	0	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	5966000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
	opk	Common Stock Options And Warrants Net Exercised CommonStockOptionsAndWarrantsNetExercised	301000	usd
	opk	Common Stock Options And Warrants Net Exercised CommonStockOptionsAndWarrantsNetExercised	1182000	usd
	opk	Stock Issued As Part Of An Acquisition Cash Flow Impact StockIssuedAsPartOfAnAcquisitionCashFlowImpact	0	usd
	opk	Stock Issued As Part Of An Acquisition Cash Flow Impact StockIssuedAsPartOfAnAcquisitionCashFlowImpact	221662000	usd
	opk	Shares Included In Business Divesture Cash Flow Impact SharesIncludedInBusinessDivestureCashFlowImpact	6689000	usd
	opk	Shares Included In Business Divesture Cash Flow Impact SharesIncludedInBusinessDivestureCashFlowImpact	172000000	usd
CY2023Q3	us-gaap	Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax	43100000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax	39900000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<i>Use of estimates</i>. The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ significantly from these estimates.
CY2023Q3	us-gaap	Inventory Write Down InventoryWriteDown	2600000	usd
	us-gaap	Inventory Write Down InventoryWriteDown	4000000	usd
CY2022Q3	us-gaap	Inventory Write Down InventoryWriteDown	3000000	usd
	us-gaap	Inventory Write Down InventoryWriteDown	4000000	usd
CY2023Q3	opk	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Goodwill And Intangible Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedGoodwillAndIntangibleAssets	1600000000	usd
CY2023Q3	us-gaap	Goodwill Goodwill	594500000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	595900000	usd
CY2023Q3	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	1000000000	usd
CY2023Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	21500000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	64500000	usd
CY2022Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	21400000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	66200000	usd
CY2023Q3	us-gaap	Depreciation Depreciation	4800000	usd
	us-gaap	Depreciation Depreciation	14800000	usd
CY2022Q3	us-gaap	Depreciation Depreciation	5000000	usd
	us-gaap	Depreciation Depreciation	16000000	usd
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023Q3	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	6000000	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 27pt;"><i>Concentration of credit risk and allowance for credit losses</i>. Financial instruments that potentially subject us to concentrations of credit risk consist primarily of accounts receivable. Substantially all of our accounts receivable are with either companies in the healthcare industry or patients. However, credit risk is limited due to the number of our clients as well as their dispersion across many different geographic regions.</p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 27pt;"> </p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 27pt;">While we have receivables due from federal and state governmental agencies, such receivables are <em style="font: inherit;">not</em> a credit risk because federal and state governments fund the related healthcare programs. Payment is primarily dependent upon submitting appropriate documentation. On <em style="font: inherit;"> September 30, 2023</em> and <em style="font: inherit;"> December 31, 2022</em>, receivable balances (net of explicit and implicit price concessions) from Medicare and Medicaid were 11.6% and 14.2%, respectively, of our consolidated Accounts receivable, net.</p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 27pt;"> </p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 27pt;">The portion of our accounts receivable due from individual patients comprises the largest portion of credit risk. At <em style="font: inherit;"> September 30, 2023</em> and <em style="font: inherit;"> December 31, 2022</em>, receivables due from patients represented approximately 2.1% and 2.9%, respectively, of our consolidated Accounts receivable, net.</p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 27pt;"> </p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 27pt;">We assess the collectability of accounts receivable balances by considering factors such as historical collection experience, customer credit worthiness, the age of accounts receivable balances, regulatory changes and current economic conditions and trends that <em style="font: inherit;"> may </em>affect a customer’s ability to pay. Actual results could differ from those estimates. The allowance for credit losses was $2.0 million and $4.2 million on <em style="font: inherit;"> September 30, 2023</em>, and <em style="font: inherit;"> December 31, 2022</em>, respectively. The credit loss expense for the <em style="font: inherit;">three</em> and <em style="font: inherit;">nine</em> months ended <em style="font: inherit;"> September 30, 2023</em>, was $98.3 thousand and $183.4 thousand, respectively. The credit loss expense for the <em style="font: inherit;">three</em> and <em style="font: inherit;">nine</em> months ended <em style="font: inherit;"> September 30, 2022</em>, was $57.9 thousand and $241.5 thousand, respectively.</p>
CY2023Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	2000000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	4200000	usd
CY2023Q3	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	98300000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	183400000	usd
CY2022Q3	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	57900000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	241500000	usd
CY2023Q3	us-gaap	Share Based Compensation ShareBasedCompensation	3200000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	8700000	usd
CY2022Q3	us-gaap	Share Based Compensation ShareBasedCompensation	3400000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	15300000	usd
CY2023Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	3800000	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	1900000	usd
CY2022Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	5800000	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	7600000	usd
CY2023Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	83074689
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	55304353
CY2022Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	82368398
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	56529876
CY2023Q3	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	18750
CY2023Q3	us-gaap	Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures	0
CY2023Q3	us-gaap	Stock Issued During Period Shares Share Based Compensation StockIssuedDuringPeriodSharesShareBasedCompensation	18750
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	18750
	us-gaap	Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures	549680
	us-gaap	Stock Issued During Period Shares Share Based Compensation StockIssuedDuringPeriodSharesShareBasedCompensation	405721
CY2022Q3	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	27750
CY2022Q3	us-gaap	Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures	937836
CY2022Q3	us-gaap	Stock Issued During Period Shares Share Based Compensation StockIssuedDuringPeriodSharesShareBasedCompensation	749550
CY2022Q3	opk	Stock Issued During Period Shares Options Exercised And Restricted Stock Units Settled StockIssuedDuringPeriodSharesOptionsExercisedAndRestrictedStockUnitsSettled	965586
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	216036
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	211187
	us-gaap	Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures	1599212
	us-gaap	Stock Issued During Period Shares Share Based Compensation StockIssuedDuringPeriodSharesShareBasedCompensation	1351637
	opk	Stock Issued During Period Shares Options Exercised And Restricted Stock Units Settled StockIssuedDuringPeriodSharesOptionsExercisedAndRestrictedStockUnitsSettled	1810399
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	458762
CY2023Q3	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	119397000	usd
CY2022Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	131474000	usd
CY2023Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1948000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	4162000	usd
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	117449000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	127312000	usd
CY2023Q3	us-gaap	Other Inventory Supplies OtherInventorySupplies	27259000	usd
CY2022Q4	us-gaap	Other Inventory Supplies OtherInventorySupplies	31275000	usd
CY2023Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	35053000	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	37139000	usd
CY2023Q3	us-gaap	Inventory Work In Process InventoryWorkInProcess	2589000	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	2449000	usd
CY2023Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	8691000	usd
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	6771000	usd
CY2023Q3	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	4632000	usd
CY2022Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	3574000	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	68960000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	74060000	usd
CY2023Q3	us-gaap	Prepaid Taxes PrepaidTaxes	7452000	usd
CY2022Q4	us-gaap	Prepaid Taxes PrepaidTaxes	8191000	usd
CY2023Q3	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	9483000	usd
CY2022Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	7918000	usd
CY2023Q3	us-gaap	Prepaid Insurance PrepaidInsurance	6667000	usd
CY2022Q4	us-gaap	Prepaid Insurance PrepaidInsurance	4496000	usd
CY2023Q3	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	1604000	usd
CY2022Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	13105000	usd
CY2023Q3	us-gaap	Other Assets Current OtherAssetsCurrent	7003000	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	6252000	usd
CY2023Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	32209000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	39962000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	461444000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	398959000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	758414000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	823520000	usd
CY2023Q3	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	38242000	usd
CY2022Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	33765000	usd
CY2023Q3	opk	Accrued Clinical Trials AccruedClinicalTrials	6328000	usd
CY2022Q4	opk	Accrued Clinical Trials AccruedClinicalTrials	4700000	usd
CY2023Q3	opk	Accrued Commitments And Contingencies Current AccruedCommitmentsAndContingenciesCurrent	5533000	usd
CY2022Q4	opk	Accrued Commitments And Contingencies Current AccruedCommitmentsAndContingenciesCurrent	4295000	usd
CY2023Q3	opk	Accrued Inventory Not Yet Billed AccruedInventoryNotYetBilled	1653000	usd
CY2022Q4	opk	Accrued Inventory Not Yet Billed AccruedInventoryNotYetBilled	7830000	usd
CY2023Q3	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	2931000	usd
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	2809000	usd
CY2023Q3	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	1911000	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	1820000	usd
CY2023Q3	us-gaap	Taxes Payable Current TaxesPayableCurrent	3720000	usd
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	5351000	usd
CY2023Q3	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	1509000	usd
CY2022Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	2323000	usd
CY2023Q3	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	1922000	usd
CY2022Q4	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	1471000	usd
CY2023Q3	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	0	usd
CY2022Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	62000	usd
CY2023Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	28619000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	33843000	usd
CY2023Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	92368000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	98269000	usd
CY2023Q3	us-gaap	Other Long Term Debt Noncurrent OtherLongTermDebtNoncurrent	7892000	usd
CY2022Q4	us-gaap	Other Long Term Debt Noncurrent OtherLongTermDebtNoncurrent	9098000	usd
CY2023Q3	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	7680000	usd
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	7089000	usd
CY2023Q3	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	136000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	138000	usd
CY2023Q3	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	0	usd
CY2022Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	974000	usd
CY2023Q3	us-gaap	Other Liabilities And Deferred Revenue Noncurrent OtherLiabilitiesAndDeferredRevenueNoncurrent	9909000	usd
CY2022Q4	us-gaap	Other Liabilities And Deferred Revenue Noncurrent OtherLiabilitiesAndDeferredRevenueNoncurrent	10072000	usd
CY2023Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	25617000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	27371000	usd
CY2022Q4	us-gaap	Goodwill Gross GoodwillGross	633874000	usd
CY2023Q3	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	38023000	usd
	opk	Goodwill Acquired Disposed Of During Period GoodwillAcquiredDisposedOfDuringPeriod	-172000	usd
	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-1222000	usd
CY2023Q3	us-gaap	Goodwill Goodwill	594457000	usd
CY2023Q3	opk	Equity Method Investment Excluding Variable Interest Entity EquityMethodInvestmentExcludingVariableInterestEntity	-0	usd
CY2023Q3	us-gaap	Equity Method Investment Underlying Equity In Net Assets EquityMethodInvestmentUnderlyingEquityInNetAssets	2348000	usd
CY2022Q4	opk	Equity Method Investment Excluding Variable Interest Entity EquityMethodInvestmentExcludingVariableInterestEntity	103000	usd
CY2022Q4	us-gaap	Equity Method Investment Underlying Equity In Net Assets EquityMethodInvestmentUnderlyingEquityInNetAssets	4120000	usd
CY2023Q3	opk	Equity Method Investment Variable Interest Entity EquityMethodInvestmentVariableInterestEntity	804000	usd
CY2023Q3	opk	Equity Method Investment Variable Interest Entity Underlying Equity In Net Assets EquityMethodInvestmentVariableInterestEntityUnderlyingEquityInNetAssets	675000	usd
CY2022Q4	opk	Equity Method Investment Variable Interest Entity EquityMethodInvestmentVariableInterestEntity	800000	usd
CY2022Q4	opk	Equity Method Investment Variable Interest Entity Underlying Equity In Net Assets EquityMethodInvestmentVariableInterestEntityUnderlyingEquityInNetAssets	1370000	usd
CY2023Q3	us-gaap	Equity Method Investments Fair Value Disclosure EquityMethodInvestmentsFairValueDisclosure	12953000	usd
CY2022Q4	us-gaap	Equity Method Investments Fair Value Disclosure EquityMethodInvestmentsFairValueDisclosure	21120000	usd
CY2023Q3	us-gaap	Equity Securities Fv Ni Current And Noncurrent EquitySecuritiesFvNiCurrentAndNoncurrent	237000	usd
CY2022Q4	us-gaap	Equity Securities Fv Ni Current And Noncurrent EquitySecuritiesFvNiCurrentAndNoncurrent	648000	usd
CY2023Q3	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	5381000	usd
CY2022Q4	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	5381000	usd
CY2023Q3	opk	Equity Investments Carrying Value Of Equity Intruments EquityInvestmentsCarryingValueOfEquityIntruments	1000	usd
CY2022Q4	opk	Equity Investments Carrying Value Of Equity Intruments EquityInvestmentsCarryingValueOfEquityIntruments	28000	usd
CY2023Q3	us-gaap	Long Term Investments LongTermInvestments	19377000	usd
CY2022Q4	us-gaap	Long Term Investments LongTermInvestments	28080000	usd
CY2023Q3	us-gaap	Equity Method Investment Quoted Market Value EquityMethodInvestmentQuotedMarketValue	1100000	usd
CY2022Q4	us-gaap	Equity Method Investment Quoted Market Value EquityMethodInvestmentQuotedMarketValue	1300000	usd
	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	-411000	usd
	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	-2999000	usd
	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	-411000	usd
	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	-2999000	usd
CY2023Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	1772000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	1720000	usd
CY2023Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	7927000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	9290000	usd
CY2023Q3	us-gaap	Long Term Debt LongTermDebt	251331000	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	256251000	usd
CY2023Q3	us-gaap	Long Term Debt LongTermDebt	251331000	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	256251000	usd
CY2023Q3	us-gaap	Line Of Credit Facility Interest Rate At Period End LineOfCreditFacilityInterestRateAtPeriodEnd		pure
CY2023Q3	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	80157000	usd
CY2023Q3	us-gaap	Line Of Credit LineOfCredit	28348000	usd
CY2022Q4	us-gaap	Line Of Credit LineOfCredit	31820000	usd
CY2022Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	1036000	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-1023000	usd
	opk	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Foreign Currency Impact FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityForeignCurrencyImpact	-13000	usd
CY2023Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	0	usd
CY2023Q3	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	0	usd
CY2022Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	1000000	usd
CY2019Q3	us-gaap	Area Of Real Estate Property AreaOfRealEstateProperty	29500
CY2019Q3	opk	Operating Leases Monthly Payments Year One OperatingLeasesMonthlyPaymentsYearOne	89000	usd
CY2019Q3	opk	Operating Leases Monthly Payments Year Five OperatingLeasesMonthlyPaymentsYearFive	101000	usd
CY2023Q3	us-gaap	Purchase Obligation PurchaseObligation	44000000	usd
	us-gaap	Contract With Customer Performance Obligation Satisfied In Previous Period ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod	19800000	usd
	us-gaap	Contract With Customer Performance Obligation Satisfied In Previous Period ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod	27800000	usd
CY2023Q3	opk	Accrued Expense Payor Overpayment Reimbursement Liability AccruedExpensePayorOverpaymentReimbursementLiability	2900000	usd
CY2022Q4	opk	Accrued Expense Payor Overpayment Reimbursement Liability AccruedExpensePayorOverpaymentReimbursementLiability	1800000	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	138000	usd
CY2023Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	136000	usd
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	2000	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-64407000	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-87820000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-87975000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-170984000	usd
CY2023Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	26183000	usd
CY2022Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	27995000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	79315000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	82195000	usd
CY2023Q3	us-gaap	Gain Loss On Investments GainLossOnInvestments	-20000	usd
CY2022Q3	us-gaap	Gain Loss On Investments GainLossOnInvestments	-43000	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	-99000	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	-359000	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	178595000	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	179744000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	681591000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	818856000	usd
CY2023Q3	us-gaap	Assets Assets	2056680000	usd
CY2022Q4	us-gaap	Assets Assets	2167259000	usd
CY2023Q3	us-gaap	Goodwill Goodwill	594457000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	595851000	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	44691000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	38725000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	12312000	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	11267000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	11628000	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	34650000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	27963000	usd
CY2023Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5Y9M18D
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y
CY2023Q3	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P6Y1M6D
CY2022Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P6Y6M
CY2023Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.06	pure
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.044	pure
CY2023Q3	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.047	pure
CY2022Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.038	pure
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	3243000	usd
CY2023Q3	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	1076000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	11060000	usd
CY2023Q3	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	3023000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	8939000	usd
CY2023Q3	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	2381000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	7334000	usd
CY2023Q3	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	1738000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	7035000	usd
CY2023Q3	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	976000	usd
CY2023Q3	opk	Lessee Operating Lease Liability Payments Due After Year Four LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour	16839000	usd
CY2023Q3	opk	Finance Lease Liability Payments Due After Year Four FinanceLeaseLiabilityPaymentsDueAfterYearFour	1920000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	54449000	usd
CY2023Q3	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	11114000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	8533000	usd
CY2023Q3	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	503000	usd
CY2023Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	45917000	usd
CY2023Q3	us-gaap	Finance Lease Liability FinanceLeaseLiability	10611000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	12000000	usd
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	2200000	usd
	us-gaap	Variable Lease Cost VariableLeaseCost	900000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	12400000	usd
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	2000000	usd
	us-gaap	Variable Lease Cost VariableLeaseCost	2000000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	11704000	usd
	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	327000	usd
	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	106000	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	1919000	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	1020000	usd
	opk	Payments For Leases PaymentsForLeases	13950000	usd
	opk	Payments For Leases PaymentsForLeases	13438000	usd

Files In Submission

Name	View Source	Status
0001437749-23-030395-index-headers.html	Edgar Link	pending
0001437749-23-030395-index.html	Edgar Link	pending
0001437749-23-030395.txt	Edgar Link	pending
0001437749-23-030395-xbrl.zip	Edgar Link	pending
ex_558970.htm	Edgar Link	pending
ex_558971.htm	Edgar Link	pending
ex_558972.htm	Edgar Link	pending
ex_558973.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
opk-20230930.xsd	Edgar Link	pending
opk20230930c_10q.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
opk-20230930_cal.xml	Edgar Link	unprocessable
opk-20230930_def.xml	Edgar Link	unprocessable
opk-20230930_lab.xml	Edgar Link	unprocessable
opk-20230930_pre.xml	Edgar Link	unprocessable
opk20230930c_10q_htm.xml	Edgar Link	completed
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$OPK
OPKO HEALTH, INC. Stock $opk

2023 Q4 Form 10-Q Financial Statement

#000143774923030395 Filed on November 06, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OPK OPKO HEALTH, INC. Stock $opk

2023 Q4 Form 10-Q Financial Statement

#000143774923030395 Filed on November 06, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OPK
OPKO HEALTH, INC. Stock $opk